^
    BIOMARKER:

    BCR-ABL1 V299L

    i
    Other names: BCR, BCR Activator Of RhoGEF And GTPase, BCR, RhoGEF And GTPase Activating Protein, Breakpoint Cluster Region Protein, Renal Carcinoma Antigen NY-REN-26, Breakpoint Cluster Region, D22S11, BCR1, BCR/FGFR1 Chimera Protein, FGFR1/BCR Chimera Protein, D22S662, ALL, CML, PHL, ABL proto-oncogene 1, ABL, c-ABL, JTK7, p150, ABL1
    Contact us to learn more about our Premium Content:
    News alerts, weekly reports and conference planners
    Entrez ID:
    25; 613
    Related biomarkers:
    Expression
    Mutation
    Fusion
    Others
    BCR-ABL1 V299L
    Acute Lymphocytic Leukemia
    dasatinib
    Resistant
    :
    A2
    BCR-ABL1 V299L
    Chronic Myeloid Leukemia
    bosutinib
    Resistant
    :
    A2
    BCR-ABL1 V299L
    Chronic Myeloid Leukemia
    dasatinib
    Resistant
    :
    A2
    BCR-ABL1 V299L
    Acute Lymphocytic Leukemia
    bosutinib
    Resistant
    :
    A2
    BCR-ABL1 V299L
    Chronic Myeloid Leukemia
    nilotinib
    Sensitive
    :
    D
    BCR-ABL1 V299L
    Acute Lymphocytic Leukemia
    crizotinib
    Sensitive
    :
    D
    BCR-ABL1 V299L
    Acute Lymphocytic Leukemia
    GSK1363089
    Sensitive
    :
    D
    BCR-ABL1 V299L
    Acute Lymphocytic Leukemia
    cabozantinib capsule
    Sensitive
    :
    D
    BCR-ABL1 V299L
    Acute Lymphocytic Leukemia
    vandetanib
    Sensitive
    :
    D
    BCR-ABL1 V299L
    Chronic Myeloid Leukemia
    imatinib
    Sensitive
    :
    D